Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Related Articles by Review for PubMed (Select 15234100)

1.

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.

Hynd MR, Scott HL, Dodd PR.

Neurochem Int. 2004 Oct;45(5):583-95. Review.

PMID:
15234100
2.

Neuropathologic changes in Alzheimer's disease: potential targets for treatment.

Wenk GL.

J Clin Psychiatry. 2006;67 Suppl 3:3-7; quiz 23. Review.

PMID:
16649845
5.

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Schaeffer EL, Gattaz WF.

Psychopharmacology (Berl). 2008 May;198(1):1-27. doi: 10.1007/s00213-008-1092-0. Epub 2008 Feb 19. Review.

PMID:
18392810
6.

Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.

Koutsilieri E, Riederer P.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S329-31. doi: 10.1016/S1353-8020(08)70025-7. Review.

PMID:
18267259
7.
8.

Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

Sonkusare SK, Kaul CL, Ramarao P.

Pharmacol Res. 2005 Jan;51(1):1-17. Review.

PMID:
15519530
9.
10.

Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity.

Arundine M, Tymianski M.

Cell Calcium. 2003 Oct-Nov;34(4-5):325-37. Review.

PMID:
12909079
11.

Amyloid beta peptides and glutamatergic synaptic dysregulation.

Parameshwaran K, Dhanasekaran M, Suppiramaniam V.

Exp Neurol. 2008 Mar;210(1):7-13. Epub 2007 Oct 24. Review.

PMID:
18053990
12.
13.

Excitatory amino acids in health and disease.

Thomas RJ.

J Am Geriatr Soc. 1995 Nov;43(11):1279-89. Review.

PMID:
7594165
14.

Glutamic acid and Alzheimer's disease.

Arias C, Becerra-García F, Tapia R.

Neurobiology (Bp). 1998;6(1):33-43. Review.

PMID:
9713830
15.

Glutamate-glutamine cycling in Alzheimer's disease.

Walton HS, Dodd PR.

Neurochem Int. 2007 Jun;50(7-8):1052-66. Epub 2006 Dec 1. Review.

PMID:
17141374
16.

[Excitatory neurotransmission in alcoholism].

Bleich S, Sperling W, Wiltfang J, Maler JM, Kornhuber J.

Fortschr Neurol Psychiatr. 2003 Jul;71 Suppl 1:S36-44. Review. German.

PMID:
12947542
17.
18.

New targets for pharmacological intervention in the glutamatergic synapse.

Gardoni F, Di Luca M.

Eur J Pharmacol. 2006 Sep 1;545(1):2-10. Epub 2006 Jun 15. Review.

PMID:
16831414
19.

Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis.

Ingram DK, Spangler EL, Iijima S, Ikari H, Kuo H, Greig NH, London ED.

Life Sci. 1994;55(25-26):2037-49. Review.

PMID:
7997063
20.

The chemical biology of clinically tolerated NMDA receptor antagonists.

Chen HS, Lipton SA.

J Neurochem. 2006 Jun;97(6):1611-26. Review.

PMID:
16805772
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk